Cash Equivalents - Accelerate Diagnostics Inc (NASDAQ:AXDX) - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.476 USD 0.41% Market Closed
Market Cap: 34.9m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Accelerate Diagnostics Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Accelerate Diagnostics Inc
Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Accelerate Diagnostics Inc
NASDAQ:AXDX
Cash Equivalents
$8.6m
CAGR 3-Years
-42%
CAGR 5-Years
-37%
CAGR 10-Years
-18%
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$4.5B
CAGR 3-Years
12%
CAGR 5-Years
54%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.9B
CAGR 3-Years
3%
CAGR 5-Years
88%
CAGR 10-Years
23%
Stryker Corp
NYSE:SYK
Cash Equivalents
$1.9B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
4%
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7B
CAGR 3-Years
-7%
CAGR 5-Years
17%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$2.6B
CAGR 3-Years
42%
CAGR 5-Years
37%
CAGR 10-Years
18%

See Also

What is Accelerate Diagnostics Inc's Cash Equivalents?
Cash Equivalents
8.6m USD

Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Cash Equivalents amounts to 8.6m USD.

What is Accelerate Diagnostics Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-18%

Over the last year, the Cash Equivalents growth was -71%. The average annual Cash Equivalents growth rates for Accelerate Diagnostics Inc have been -42% over the past three years , -37% over the past five years , and -18% over the past ten years .

Back to Top